CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection
- 31 May 2001
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 158 (5), 1703-1711
- https://doi.org/10.1016/s0002-9440(10)64126-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- CXC Chemokines IP-10 and Mig Expression and Direct Migration of Pulmonary CD8 + /CXCR3 + T Cells in the Lungs of Patients with HIV Infection and T-Cell AlveolitisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous DiseaseThe American Journal of Pathology, 2000
- Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantationThorax, 2000
- Eosinophilic alveolitis in BAL after lung transplantationTransplant International, 1999
- Lung TransplantationNew England Journal of Medicine, 1999
- Th1- and Th2-Type Cytokines Regulate the Expression and Production of Eotaxin and RANTES by Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Endobronchial Biopsy and Bronchoalveolar Lavage in Stable Lung Transplant Recipients and Chronic RejectionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- OBLITERATIVE BRONCHIOLITISClinics in Chest Medicine, 1997
- INTRAPULMONARY PRODUCTION OF RANTES DURING REJECTION AND CMV PNEUMONITIS AFTER LUNG TRANSPLANTATION1Transplantation, 1996